BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 36758032)

  • 1. Sodium/Iodide Symporter Metastable Intermediates Provide Insights into Conformational Transition between Principal Thermodynamic States.
    Chakrabarti M; Amzel LM; Lau AY
    J Phys Chem B; 2023 Feb; 127(7):1540-1551. PubMed ID: 36758032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The sodium/iodide symporter: state of the art of its molecular characterization.
    Darrouzet E; Lindenthal S; Marcellin D; Pellequer JL; Pourcher T
    Biochim Biophys Acta; 2014 Jan; 1838(1 Pt B):244-53. PubMed ID: 23988430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Sodium/Iodide Symporter (NIS): Molecular Physiology and Preclinical and Clinical Applications.
    Ravera S; Reyna-Neyra A; Ferrandino G; Amzel LM; Carrasco N
    Annu Rev Physiol; 2017 Feb; 79():261-289. PubMed ID: 28192058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural insights into the mechanism of the sodium/iodide symporter.
    Ravera S; Nicola JP; Salazar-De Simone G; Sigworth FJ; Karakas E; Amzel LM; Bianchet MA; Carrasco N
    Nature; 2022 Dec; 612(7941):795-801. PubMed ID: 36517601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physiological sodium concentrations enhance the iodide affinity of the Na+/I- symporter.
    Nicola JP; Carrasco N; Amzel LM
    Nat Commun; 2014 Jun; 5():3948. PubMed ID: 24888603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sodium/iodide-symporter: distribution in different mammals and role in entero-thyroid circulation of iodide.
    Josefsson M; Grunditz T; Ohlsson T; Ekblad E
    Acta Physiol Scand; 2002 Jun; 175(2):129-37. PubMed ID: 12028133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of sodium iodide symporter gene expression in FRTL-5 rat thyroid cells.
    Spitzweg C; Joba W; Morris JC; Heufelder AE
    Thyroid; 1999 Aug; 9(8):821-30. PubMed ID: 10482376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Na+ coordination at the Na2 site of the Na+/I- symporter.
    Ferrandino G; Nicola JP; Sánchez YE; Echeverria I; Liu Y; Amzel LM; Carrasco N
    Proc Natl Acad Sci U S A; 2016 Sep; 113(37):E5379-88. PubMed ID: 27562170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Escape from the acute Wolff-Chaikoff effect is associated with a decrease in thyroid sodium/iodide symporter messenger ribonucleic acid and protein.
    Eng PH; Cardona GR; Fang SL; Previti M; Alex S; Carrasco N; Chin WW; Braverman LE
    Endocrinology; 1999 Aug; 140(8):3404-10. PubMed ID: 10433193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of anion selectivity and stoichiometry of the Na+/I- symporter (NIS).
    Paroder-Belenitsky M; Maestas MJ; Dohán O; Nicola JP; Reyna-Neyra A; Follenzi A; Dadachova E; Eskandari S; Amzel LM; Carrasco N
    Proc Natl Acad Sci U S A; 2011 Nov; 108(44):17933-8. PubMed ID: 22011571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The practical relevance of the sodium iodide symporter].
    Spitzweg C
    Z Arztl Fortbild Qualitatssich; 2004 May; 98 Suppl 5():25-32. PubMed ID: 15255310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Q267E mutation in the sodium/iodide symporter (NIS) causes congenital iodide transport defect (ITD) by decreasing the NIS turnover number.
    De La Vieja A; Ginter CS; Carrasco N
    J Cell Sci; 2004 Feb; 117(Pt 5):677-87. PubMed ID: 14734652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation and tissue distribution of the human sodium iodide symporter gene.
    Ajjan RA; Kamaruddin NA; Crisp M; Watson PF; Ludgate M; Weetman AP
    Clin Endocrinol (Oxf); 1998 Oct; 49(4):517-23. PubMed ID: 9876351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydrocortisone and purinergic signaling stimulate sodium/iodide symporter (NIS)-mediated iodide transport in breast cancer cells.
    Dohán O; De la Vieja A; Carrasco N
    Mol Endocrinol; 2006 May; 20(5):1121-37. PubMed ID: 16439463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AMP-activated protein kinase activation leads to lysome-mediated NA(+)/I(-)-symporter protein degradation in rat thyroid cells.
    Cazarin JM; Andrade BM; Carvalho DP
    Horm Metab Res; 2014 May; 46(5):313-7. PubMed ID: 24691731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphoinositide-3-kinase inhibition induces sodium/iodide symporter expression in rat thyroid cells and human papillary thyroid cancer cells.
    Kogai T; Sajid-Crockett S; Newmarch LS; Liu YY; Brent GA
    J Endocrinol; 2008 Nov; 199(2):243-52. PubMed ID: 18762555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a screening approach to detect thyroid disrupting chemicals that inhibit the human sodium iodide symporter (NIS).
    Hallinger DR; Murr AS; Buckalew AR; Simmons SO; Stoker TE; Laws SC
    Toxicol In Vitro; 2017 Apr; 40():66-78. PubMed ID: 27979590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [
    Jiang H; DeGrado TR
    Theranostics; 2018; 8(14):3918-3931. PubMed ID: 30083270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The acute inhibitory effect of iodide excess on sodium/iodide symporter expression and activity involves the PI3K/Akt signaling pathway.
    Serrano-Nascimento C; da Silva Teixeira S; Nicola JP; Nachbar RT; Masini-Repiso AM; Nunes MT
    Endocrinology; 2014 Mar; 155(3):1145-56. PubMed ID: 24424051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MEK signaling modulates sodium iodide symporter at multiple levels and in a paradoxical manner.
    Vadysirisack DD; Venkateswaran A; Zhang Z; Jhiang SM
    Endocr Relat Cancer; 2007 Jun; 14(2):421-32. PubMed ID: 17639055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.